Certara is dedicated to improving human health by offering a broad spectrum of software products and services, with special focus on supporting translational approaches to drug development.
Access, visualize, and analyze drug discovery, pre-clinical and clinical data.
Predictive science for drug discovery and other life sciences
Conduct simulations in virtual patient populations based on in vitro and clinical data.
Analyze, manage, report, and validate preclinical and clinical data.
Minimize risks and guide decision making for drug trials.
Assess cardiac safety risks in drug candidates.
Support your strategic drug development decisions and new drug approvals through quantitative analysis and predictive models of diseases, drugs and clinical trials.
Consultancy and guidance on a broad spectrum of DMPK issues, including optimal design for metabolic drug-drug interaction studies, interpretation of data and prediction of in vivo ADME from in vitro studies.
Multi-disciplinary expert scientific team with expertise in pharmacometrics, PK analysis and programming, biostatistics, and medical writing.
Our team of scientists has supported over 50 recent drug approvals, labels, and submissions through biosimulation
Find papers, presentations, & webinars about scientific informatics, PK/PD modeling & simulation, PBPK modeling & simulation, and molecular modeling.
Access to some of our resources requires a registered account and "Log In" is required.
Read the latest company announcements, find out about upcoming events where you can meet Certara scientists and representatives, and sign up for upcoming webinars.
From Discovery through Development
May 28, 2015
May 19, 2015
April 30, 2015
All News Articles
May 31 - June 1, 2015
June 2-5, 2015
June 8-10, 2015
Site Map | Careers | Contact Us | Legal
© 2011-2015 Certara, L.P., All rights reserved.
Certara USA, Inc.
100 Overlook Center, Suite 101
Princeton, NJ 08540 USA